QuickView for benserazide (compound)

PubChem

Name:	Benserazide
PubChem Compound ID:	2327
Description:	An inhibitor of DOPA DECARBOXYLASE that does not enter the central nervous system. It is often given with LEVODOPA in the treatment of parkinsonism to prevent the conversion of levodopa to dopamine in the periphery, thereby increasing the amount that reaches the central nervous system and reducing the required dose. It has no antiparkinson actions when given alone.
Molecular formula:	C₁₀H₁₅N₃O₅
Molecular weight:	257.243 g/mol
Synonyms:	DivK1c_000469; Ro 4-4602; Serine, 2-(2,3,4-trihydroxybenzyl)hyrazide, DL-; D03082; KBio2_005606; BRN 3984490; KBio3_001404; Spectrum3_000312; Benserazide (USAN); SPBio_000220. show more » DivK1c_000469; Ro 4-4602; Serine, 2-(2,3,4-trihydroxybenzyl)hyrazide, DL-; D03082; KBio2_005606; BRN 3984490; KBio3_001404; Spectrum3_000312; Benserazide (USAN); SPBio_000220; Spectrum2_000140; DL-Serine 2-(2,3,4-trihydroxybenzyl)hydrazide; DL-Seryltrihydroxybenzylhydrazine; DL-Serine, 2-((2,3,4-trihydroxyphenyl)methyl)hydrazide; Madopa; KBio2_000470; Benserazide [USAN:BAN:INN]; Benserazidum [INN-Latin]; NINDS_000469; KBioGR_000654; KBioSS_000470; Serine, 2-(2,3,4-trihydroxybenzyl)hydrazide, dl-; KBio1_000469; 322-35-0; Benserazida [INN-Spanish]; Benserazide; KBio2_003038; Prestwick0_000938; Prestwick1_000938; Spectrum4_000247; Spectrum_000070; SPBio_003045; Serazide show less «